Abstract

Sir, Saccharomyces cerevisiae is a ubiquitous yeast used as a probiotic for antibiotic-associated diarrhea prophylaxis. It is part of the normal flora of the oral, gastrointestinal, and respiratory tracts and the vaginal lining. Severe opportunistic infections due to S. cerevisiae have been reported in patients with immunosuppression with fungemia, endocarditis, pneumonia, and urinary tract infection [1–3]. Herein, we describe the first case in the literature of a skin infection with S. cerevisiae in an immunocompetent patient. A 72-year-old patient with no particular history had had pruriginous skin lesions for five years in the context of general state preservation and apyrexia. A skin examination revealed erythematous and maculopapular lesions diffused throughout the body (Figs. 1a−1d). The phaners and mucous membranes were without abnormality, and there was no adenopathy. The rest of the examination was unremarkable. The patient had been treated several times with topical and oral antifungals and dermocorticoids but without any improvement.

Highlights

  • A 72-year-old patient with no particular history had had pruriginous skin lesions for five years in the context of general state preservation and apyrexia

  • Two mycological examinations of the skin lesions revealed the presence of S. cerevisiae (Figs. 2 and 3)

  • Invasive S. cerevisiae infections have been identified for the past three decades, with the microorganisms recovered from the blood, lungs, esophagi, peritoneal cavities, urinary tracts, and vaginas

Read more

Summary

Introduction

A 72-year-old patient with no particular history had had pruriginous skin lesions for five years in the context of general state preservation and apyrexia. Two mycological examinations of the skin lesions revealed the presence of S. cerevisiae The patient proceeded against medical advice and discontinued attendance without treatment. The genus Saccharomyces comprises several species, with the most well-known being S. cerevisiae.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call